Ensemble licenses IL-17 program to Novartis

Ensemble Therapeutics Corp. (Cambridge, Mass.) granted Novartis AG (NYSE:NVS; SIX:NOVN) exclusive, worldwide rights to its lead program of

Read the full 188 word article

How to gain access

Continue reading with a
two-week free trial.